These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2207360)

  • 1. [Pharmacologic bases of chemotherapy of brain tumors in children].
    Vassal G
    Bull Cancer; 1990; 77(7):699-713. PubMed ID: 2207360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
    Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
    J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
    Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The blood-brain barrier: implications for chemotherapy in brain tumors].
    Boaziz C; Breau JL; Morère JF; Israël L
    Pathol Biol (Paris); 1991 Oct; 39(8):789-95. PubMed ID: 1762838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
    Deeken JF; Löscher W
    Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
    Kemper EM; Boogerd W; Thuis I; Beijnen JH; van Tellingen O
    Cancer Treat Rev; 2004 Aug; 30(5):415-23. PubMed ID: 15245774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
    Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
    Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm.
    Gerstner ER; Fine RL
    J Clin Oncol; 2007 Jun; 25(16):2306-12. PubMed ID: 17538177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
    Neuwelt EA; Gilmer-Knight K; Lacy C; Nicholson HS; Kraemer DF; Doolittle ND; Hornig GW; Muldoon LL
    Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of chemotherapy in the treatment of brain tumors].
    Chastagner P; Sommelet D
    Pediatrie; 1991; 46(1):47-58. PubMed ID: 1851283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier and treatment of central nervous system tumors.
    Wiranowska M
    J Fla Med Assoc; 1992 Oct; 79(10):707-10. PubMed ID: 1460453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery to brain tumours: challenges and progress.
    Ningaraj NS
    Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
    de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
    Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
    Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
    Neuwelt EA; Rapoport SI
    Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours.
    Koukourakis MI; Koukouraki S; Fezoulidis I; Kelekis N; Kyrias G; Archimandritis S; Karkavitsas N
    Br J Cancer; 2000 Nov; 83(10):1281-6. PubMed ID: 11044350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusion rates and drug distribution in brain tumor models in rats.
    Khan A; Jallo GI; Liu YJ; Carson BS; Guarnieri M
    J Neurosurg; 2005 Jan; 102(1 Suppl):53-8. PubMed ID: 16206734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.